SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-16-039385
Filing Date
2016-10-03
Accepted
2016-10-03 16:30:22
Documents
1
Period of Report
2016-09-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 FORM 8-K acrx20161003_8k.htm 8-K 20689
  Complete submission text file 0001437749-16-039385.txt   21866
Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35068 | Film No.: 161916039
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1